Institutional Ownership
Innate Pharma S A
CUSIP 45781K204SPONSORED ADSIPHAQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
9
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lion Point Capital, LP | 81.2K | $103.9K |
| 2 | Morgan Stanley | 43.5K | $55.7K |
| 3 | Jane Street Group, LLC | 43.4K | $55.5K |
| 4 | Millennium Management LLC | 10.1K | $12.9K |
| 5 | Rhumbline Advisers | 4.7K | $6.1K |
| 6 | Ubs Group AG | 861 | $1.1K |
| 7 | Gamma Investing LLC | 240 | $307 |
| 8 | Farther Finance Advisors, LLC | 10 | $14 |
| 9 | Caitong International Asset Management Co., Ltd | 2 | $3 |